中文版
js_thumb bannerPic
/
Chemotherapy Gene Testing

Technical Services

Chemotherapy Gene Testing

Description:Chemotherapy is currently the most commonly used method in the treatment of tumors (cancers). However, there are obvious individual differences in the sensitivity of tumors to various chemotherapeutic drugs, that is, different tumor types or different patients of the same type, or even the same patient at different stages of onset, the sensitivity to chemotherapy is not exactly the same, the treatment effect The difference is also great.
Description:Chemotherapy is currently the most commonly used method in the treatment of tumors (cancers). However, there are obvious individual differences in the sensitivity of tumors to various chemotherapeutic drugs, that is, different tumor types or different patients of the same type, or even the same patient at different stages of onset, the sensitivity to chemotherapy is not exactly the same, the treatment effect The difference is also great.
Information

Chemotherapy Gene Testing

2.1 Tumor chemotherapy drug gene detection

Chemotherapy is currently the most commonly used method in the treatment of tumors (cancers). However, there are obvious individual differences in the sensitivity of tumors to various chemotherapeutic drugs, that is, different tumor types or different patients of the same type, or even the same patient at different stages of onset, the sensitivity to chemotherapy is not exactly the same, the treatment effect The difference is also great. Pharmacogenomics studies have shown that the efficacy and toxic side effects of some drugs are closely related to differences in individual genes. Polymorphisms at these related gene loci are detected to accurately screen sensitive chemotherapy drugs for different patients and determine their doses. Fundamentally alleviate the suffering of tumor patients, improve the quality of life of patients, and increase the survival probability of patients.

This product uses fluorescence quantitative PCR, time-of-flight mass spectrometry (MALDI-TOF-MS), and Sanger sequencing methods to detect mutations in genes associated with commonly used chemotherapeutic drugs and assist doctors in formulating the most appropriate individualized treatment plan, making tumor treatment more accurate High efficiency, so as to achieve the goal of extending the survival time of patients and improving the quality of life of patients.

 

Product ID

Product name

Detection cycle

Sample type

T10

Colorectal cancer chemotherapy drug gene test

7 working days

Peripheral blood (EDTA anticoagulant tube, purple cap) + paraffin section / paraffin roll / fresh tissue

T11

Lung cancer chemotherapy drug gene test

7 working days

Peripheral blood (EDTA anticoagulant tube, purple cap)

T12

Breast cancer chemotherapy drug gene test

7 working days

T13

Genetic testing for other cancer chemotherapy drugs

7 working days

 

2.1 Genetic testing for individualized tumor treatment

Personalized drug gene detection uses target area capture combined with high-throughput sequencing technology to provide individualized diagnosis and treatment of tumor patients based on cancer tissue samples. Selecting drugs related to cancer treatment, including chemotherapy drugs, FDA-approved targeted drugs and drugs in clinical trials, it can comprehensively interpret the genes related to cancer drugs at one time.

Individualized diagnosis and treatment gene detection and circulating tumor DNA non-invasive gene detection uses target area capture combined with high-throughput sequencing technology to provide individualized diagnosis and treatment gene detection for cancer patients based on cancer tissue samples or peripheral blood. It can comprehensively interpret 578 genes related to tumor drugs and tumorigenesis at one time, assist doctors in selecting the most suitable drugs for patients, formulate more comprehensive treatment plans, and maximize the satisfaction of patients' personalized treatment needs in order to extend patients. The purpose of survival time and improving the quality of life.

 

Product ID

Product name

Detection cycle

Sample type

T14

Individualized drug genetic testing

10-15 natural days

Fresh tissue + peripheral blood (EDTA anticoagulant tube, purple cap) (preferred); paraffin section / paraffin roll + peripheral blood (EDTA anticoagulant tube, purple cap)

T15

Individualized diagnosis and treatment gene testing

10-15 natural days

 

T16

Non-invasive genetic testing for circulating tumor DNA

10-15 natural days

Peripheral blood (Streck Cell-Free DNA blood collection tube)

T17

Breast cancer risk (RS) assessment genetic testing

7 working days

Paraffin section

 

 

Keyword: gene treatment drugs cancer tumor

Scan the QR code to read on your phone

Search
Search

Suzhou Office: Building 1, No. 188, Fuchunjiang Road, High-tech Zone, Suzhou
Beijing Office: Building 2, No. 28, Yuhua Road, Airport Science and Technology Park, Shunyi District, Beijing
Contact number:
+86-10-80497001
Nantong Office: No. 888 Zhujiang Road, Juegang Street, Rudong County, Jiangsu Province
Contact number:
+86-513-80562882
Company email: info@hongweitest.com

Macro micro-test

WeChat

Copyright © 2021 Jiangsu Macro & Micro-Test Med-Tech Co.,Ltd.苏ICP备18057655号 苏公网安备 32062302000215号 Power by:300.cn
Suspended
返回顶部